Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL?

Cardiovascular and Interventional Radiology
Yan ZhaoJean-François Geschwind

Abstract

Our study aimed to evaluate quantitative tumor response assessment (quantitative EASL-[qEASL]) on computed tomography (CT) images in patients with hepatocellular carcinoma (HCC) treated using conventional transarterial chemoembolization (cTACE), compared to existing 1-dimensional and 2-dimensional methods (RECIST, mRECIST, EASL). In this IRB-approved, single-institution retrospective cohort study, 52 consecutive patients with intermediate-stage HCC were consecutively included. All patients underwent contrast-enhanced CT scan at baseline and 4 weeks after cTACE. Median follow-up period was 13.5 months (range 1.2-54.1). RECIST, mRECIST and EASL identified progression in 2 (4%), 1 (2%) and 1 (2%) patients, respectively, whereas qEASL identified 10 (19%) patients. qEASL was the only tumor response method able to predict survival among different tumor response groups (P < 0.05), whereas RECIST, mRECIST and EASL did not (P > 0.05). Both EASL and qEASL were able to identify responders and non-responders and were predictive of survival (P < 0.05). Multivariate analysis showed that progression was an independent predictor of overall survival with hazard ratio of 1.9 (P = 0.025). Patients who demonstrated progression with qEASL had signi...Continue Reading

References

Jul 22, 2004·The Oncologist·Dushyant V Sahani, Sanjeeva P Kalva
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Feb 23, 2010·Seminars in Liver Disease·Riccardo Lencioni, Josep M Llovet
Nov 12, 2010·Cardiovascular and Interventional Radiology·Eleni Liapi, Jean-Francois H Geschwind
Mar 20, 2012·Journal of Hepatology·UNKNOWN European Association For The Study Of The Liver, UNKNOWN European Organisation For Research And Treatment Of Cancer
Dec 12, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Beom Kyung KimChae Yoon Chon
Oct 11, 2013·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Fernanda D Gonzalez-GuindaliniVahid Yaghmai
Feb 5, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lei LiuGuohong Han
Apr 13, 2015·Academic Radiology·Zhijun WangMingDe Lin
Sep 24, 2015·Cardiovascular and Interventional Radiology·Thierry de BaereMichael C Soulen

❮ Previous
Next ❯

Citations

Nov 11, 2018·European Radiology·Hasmik KoulakianMaxime Ronot
Aug 3, 2019·Nature Reviews. Gastroenterology & Hepatology·Jordi BruixMaría Reig
Mar 7, 2020·World Journal of Clinical Oncology·Nuri Faruk Aykan, Tahsin Özatlı
Jan 24, 2021·Journal of the American College of Radiology : JACR·Xiao WuAjay Malhotra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.